+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Lung Cancer Surgery - Global Strategic Business Report 2026

  • PDF Icon

    Report

  • 453 Pages
  • November 2026
  • Region: Global
  • Market Glass, Inc.
  • ID: 4805581
The global market for Lung Cancer Surgery was valued at US$1.4 Billion in 2025 and is projected to reach US$1.9 Billion by 2032, growing at a CAGR of 4.7% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Lung Cancer Surgery Market - Key Trends & Drivers Summarized

Why Is Lung Cancer Surgery a Critical Component of Cancer Treatment Today?

Lung cancer remains one of the most prevalent and deadly cancers worldwide, making effective treatment modalities like surgery crucial in the fight against this disease. Surgery for lung cancer involves the removal of the tumor and surrounding lung tissue where cancer cells may have spread. This approach is generally most effective in the early stages of lung cancer, specifically non-small cell lung cancer (NSCLC), where the tumor is localized and operable. Advances in surgical techniques, including minimally invasive procedures such as video-assisted thoracic surgery (VATS) and robot-assisted surgery, have significantly improved outcomes for patients. These techniques reduce surgical trauma and recovery time, decrease the risk of complications, and can improve the quality of life post-surgery compared to traditional open surgery. As detection methods improve and more lung cancers are diagnosed at an operable stage, the role of surgery in treatment regimens continues to expand.

How Are Technological Advances Transforming Lung Cancer Surgery?

The landscape of lung cancer surgery has been transformed by technological advancements that allow for more precise and less invasive procedures. Innovations such as robotic surgery provide surgeons with enhanced dexterity and control, enabling them to perform complex dissections and remove tumors with high precision while preserving healthy tissue. Furthermore, intraoperative imaging technologies like real-time CT scans and fluorescence imaging have improved the accuracy of tumor localization and the assessment of resection margins, ensuring that more of the cancerous tissue is removed during the initial surgery. These advancements not only increase the success rate of surgical interventions but also minimize the physical impact on patients, leading to faster recovery times and less postoperative discomfort.

What Impact Do Early Detection and Personalized Treatment Have on Lung Cancer Surgery Outcomes?

Early detection and personalized treatment approaches are significantly influencing outcomes in lung cancer surgery. The development of low-dose CT screening for high-risk individuals has led to earlier diagnosis of lung cancer, often at a stage when surgical resection is possible and more likely to be curative. Personalized medicine, which involves genetic profiling of tumors to understand their unique characteristics, has also made strides in determining which patients are good candidates for surgery and how they might best respond to additional treatments such as chemotherapy or targeted therapy. This tailored approach helps in strategizing treatment plans that maximize the efficacy of surgery and minimize unnecessary treatments, thereby improving overall patient survival and quality of life.

Growth in the Lung Cancer Surgery Market Is Driven by Several Factors

The growth in the lung cancer surgery market is driven by several factors, encompassing technological advancements, improved detection methods, and an increased emphasis on personalized medicine. Technological innovations in surgical techniques, including minimally invasive and robotic-assisted surgeries, have broadened the range of operable cases and improved patient outcomes, making surgery a more viable option for many patients. Enhanced screening programs have also played a critical role, as they increase the number of early-stage cancers identified, where surgical intervention can be most beneficial. Additionally, as understanding of the genetic basis of lung cancer improves, personalized surgical treatments are becoming more prevalent, allowing for more targeted and effective interventions. These developments, combined with a growing awareness of lung cancer risks and prevention, continue to drive the demand for surgical solutions in the treatment of lung cancer, reflecting a dynamic and evolving marketplace.

Report Scope

The report analyzes the Lung Cancer Surgery market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:
  • Segments: Product Type (Thoracoscopes Product Type, Mediastinoscopes Product Type, Bronchoscopes Product Type, Robotic Assisted Thoracic Surgery Systems Product Type, Surgical Staplers Product Type, Surgical Energy Instruments Product Type); Application (Segmentectomy Application, Lobectomy Application, Wedge Resection Application, Pneumonectomy Application); End-Use (Hospitals End-Use, Ambulatory Surgery Centers End-Use).
  • Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Thoracoscopes Product Type segment, which is expected to reach US$501.2 Million by 2032 with a CAGR of a 4%. The Mediastinoscopes Product Type segment is also set to grow at 6.1% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $377.1 Million in 2025, and China, forecasted to grow at an impressive 7.9% CAGR to reach $396.6 Million by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Lung Cancer Surgery Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Lung Cancer Surgery Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Lung Cancer Surgery Market expected to evolve by 2032?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2032?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Abbott Molecular, Inc., AbbVie, Inc., Accuray, Inc., AngioDynamics, Inc., Baxter International, Inc. and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this Lung Cancer Surgery market report include:

  • Abbott Molecular, Inc.
  • AbbVie, Inc.
  • Accuray, Inc.
  • AngioDynamics, Inc.
  • Baxter International, Inc.
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • Daiichi Sankyo Co., Ltd.
  • Medtronic Plc
  • Olympus Corporation
  • Siemens Healthineers
  • Teleflex Incorporated

What Sets This Report Apart From Others?

  • Grounded in Domain Expert Perspectives: Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.
  • Captures Early Market Signals: Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.
  • Draws From a Broad, Validated Intelligence Base: Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.
  • Connects Signals With Strategic Market Direction: Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.
  • Provides In-Depth Company Intelligence: Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.
  • Market Share Is Examined Where It Matters: A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, our reports extend market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind
  • Lung Cancer Surgery - Global Key Competitors Percentage Market Share in 2026 (E)
  • Global Economic Update
  • Competitive Market Presence - Strong/Active/Niche/Trivial for 111 Players Worldwide in 2026 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Advancements in Minimally Invasive Surgical Techniques Propel Growth in Lung Cancer Surgery
  • Integration of Robotic-Assisted Systems Accelerates Demand for Precision Lung Cancer Surgery
  • Innovations in Imaging and Intraoperative Navigation Expand the Addressable Market Opportunity for Lung Cancer Surgery
  • Enhanced Preoperative Diagnostics Drives Adoption of Targeted Lung Cancer Surgical Procedures
  • Digital Transformation in Surgical Planning Generates Demand for Advanced Lung Cancer Surgery Technologies
  • Rising Incidence of Lung Cancer Strengthens the Business Case for Cutting-Edge Surgical Interventions
  • Increasing Adoption of Personalized Treatment Protocols Spurs Growth in Demand for Lung Cancer Surgery
  • Enhanced Multidisciplinary Care Models Throws the Spotlight On Comprehensive Lung Cancer Surgery Approaches
  • Strategic Collaborations Between Medical Device Manufacturers and Healthcare Providers Propel Innovation in Lung Cancer Surgery
  • Integration of AI and Machine Learning in Treatment Planning Accelerates Demand for Next-Generation Lung Cancer Surgery
  • Advances in Intraoperative Imaging and Real-Time Monitoring Generate Opportunities for Improved Surgical Precision
  • Shifting Regulatory Standards for Cancer Treatment Drive Adoption of Advanced Lung Cancer Surgery Techniques
  • Emergence of Targeted Therapies and Neoadjuvant Treatments Expands the Market for Lung Cancer Surgical Solutions
  • Enhanced Recovery After Surgery Protocols Strengthen the Business Case for Minimally Invasive Lung Cancer Surgery
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Lung Cancer Surgery Market Analysis of Annual Sales in US$ Thousand for Years 2020 through 2032
  • Table 2: World Recent Past, Current & Future Analysis for Lung Cancer Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 3: World Historic Review for Lung Cancer Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 4: World 13-Year Perspective for Lung Cancer Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
  • Table 5: World Recent Past, Current & Future Analysis for Thoracoscopes Product Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 6: World Historic Review for Thoracoscopes Product Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 7: World 13-Year Perspective for Thoracoscopes Product Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 8: World Recent Past, Current & Future Analysis for Mediastinoscopes Product Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 9: World Historic Review for Mediastinoscopes Product Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 10: World 13-Year Perspective for Mediastinoscopes Product Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 11: World Recent Past, Current & Future Analysis for Bronchoscopes Product Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 12: World Historic Review for Bronchoscopes Product Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 13: World 13-Year Perspective for Bronchoscopes Product Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 14: World Recent Past, Current & Future Analysis for Robotic Assisted Thoracic Surgery Systems Product Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 15: World Historic Review for Robotic Assisted Thoracic Surgery Systems Product Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 16: World 13-Year Perspective for Robotic Assisted Thoracic Surgery Systems Product Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 17: World Recent Past, Current & Future Analysis for Surgical Staplers Product Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 18: World Historic Review for Surgical Staplers Product Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 19: World 13-Year Perspective for Surgical Staplers Product Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 20: World Recent Past, Current & Future Analysis for Surgical Energy Instruments Product Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 21: World Historic Review for Surgical Energy Instruments Product Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 22: World 13-Year Perspective for Surgical Energy Instruments Product Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 23: World Recent Past, Current & Future Analysis for Segmentectomy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 24: World Historic Review for Segmentectomy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 25: World 13-Year Perspective for Segmentectomy Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 26: World Recent Past, Current & Future Analysis for Lobectomy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 27: World Historic Review for Lobectomy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 28: World 13-Year Perspective for Lobectomy Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 29: World Recent Past, Current & Future Analysis for Wedge Resection Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 30: World Historic Review for Wedge Resection Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 31: World 13-Year Perspective for Wedge Resection Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 32: World Recent Past, Current & Future Analysis for Pneumonectomy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 33: World Historic Review for Pneumonectomy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 34: World 13-Year Perspective for Pneumonectomy Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 35: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 36: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 37: World 13-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 38: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 39: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 40: World 13-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
III. MARKET ANALYSIS
UNITED STATES
  • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
CANADA
JAPAN
  • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
CHINA
  • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
EUROPE
  • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
FRANCE
  • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
GERMANY
  • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
ITALY
UNITED KINGDOM
  • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
AUSTRALIA
  • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
INDIA
  • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Molecular, Inc.
  • AbbVie, Inc.
  • Accuray, Inc.
  • AngioDynamics, Inc.
  • Baxter International, Inc.
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • Daiichi Sankyo Co., Ltd.
  • Medtronic Plc
  • Olympus Corporation
  • Siemens Healthineers
  • Teleflex Incorporated

Table Information